| Description |
1 online resource. |
|
text file |
|
PDF |
| Series |
Public health ethics analysis, 2211-6680 ; volume 5 |
|
Public health ethics analysis ; v. 5.
|
| Bibliography |
Includes bibliographical references and index. |
| Contents |
Part I Ethics and drug resistance in context -- 1 Drug-resistant infection : causes, consequences, and responses / Euzebiusz Jamrozik and Michael Selgelid -- 2 Preventive therapy for multidrug resistant latent Tuberculosis infection : an ethical imperative with ethical barriers to implementation? / Binh Nguyen, Greg J. Fox, Paul H. Mason, and Justin T. Denholm -- 3 Providing universal access while avoiding antiretroviral resistance : ethical tensions in HIV treatment / Bridget Haire -- 4 Ethics and animalarial drug resistance / Phaik Yeong Cheah, Michael Parker, and Nicholas P.J. Day -- 5 Antimicrobial resistance and the private sector in Southeast Asia / Marco Liverani, Lauren Oliveira Hashiguchi, Mishal Khan, and Richard Coker -- 6 Hospital infection prevention and control (IPC) and antimicrobial stewardship (AMS) : dual strategies to reduce antibiotic resistance (ABR) in hospitals / Gwendolyn L. Gilbert and Ian Kerridge -- 7 Epidemiology and ethics of antimicrobial resistance in animals / Lisa Boden and Dominic Mellor -- Part II Theoretical approaches to ethics and drug resistance -- 8 The virtuous physician and antimicrobial prescribing policy and practice / Justin Oakley -- 9 Moral resonsibility and the justification of policies to preserve antimicrobial effectiveness / Alberto Giubilini and J. Savulescu -- 10 Access to effective diagnosis and treatment for drug-resistant Tuberculosis : deepening the human rights-based approach / Remmy Shawn, Fons Coomans, Helen Cox, and Leslie London -- 11 The Right to refuse treatment for infectious disease / Carl H. Coleman -- 12 Surveillance and control of asymptomatic carriers of drug-resistant bacteria / Euzebiusz Jamrozik and Michael Selgelid -- 13 Conceptualizing the impact of MDRO control measures directed at carriers : a capability approach / Morten Fibieger Byskov, Babette Olga Rump, and Marcel Verweij -- 14 A capability perspective on antibiotic resistance, inequality, and child development / Michael Millar -- 15 Fairness in the use of information about carriers of resistant infections / John G. Francis and Leslie P. Francis -- 16 Antimicrobial resistance and social inequalities in health : considerations of justice / Lynette Reid -- 17 The economics of resistance through an ethical lens / Richard D. Smith and Joanna Coast -- Part III Ethics, regulation, governance, and drug resistance -- 18 Antibiotics and animal agriculture : the need for global collective action / Jonathan Anomaly -- 19 Technological fixes and antimicrobial resistance / Nicholas B. King |
|
20 Tackling anti-microbial resistance : an ethical framework for rational antibiotic use / Jasper Littmann, Annette Rid, and Alena Buyx -- 21 Solidarity and antimicrobial resistance / Søren Holm and Thomas Ploug -- 22 Justifying antibiotic resistance interventions : uncertainty, precaution and ethics / Niels Nijsingh, D.G. Joakim Larsson, Karl de Fine Licht, and Christian Munthe -- 23 Antimicrobial footprints, fairness, and collective harm / Anne Schwenkenbecher -- 24 Global health governance and antimicrobial resistance / Belinda Bennett and Jon Iredell -- 25 Global governance of anti-microbial resistance : a legal and regulatory toolkit / Calvin W. L. Ho and Tsung-Ling Lee -- 26 The super-wicked problem of antimicrobial resistance / Jasper Littmann, A.M. Viens, and Diego S. Silva. |
| Summary |
This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century. |
| Note |
Online resource; title from digital title page (viewed on December 24, 2020). |
| Subject |
Bioethics.
|
|
Drug resistance.
|
|
Communicable diseases.
|
|
Medical ethics.
|
|
World health.
|
|
Drug Resistance https://id.nlm.nih.gov/mesh/D004351 -- ethics.
|
|
Ethics, Medical. (DNLM)D004992
|
|
Global Health. (DNLM)D014943
|
|
Social Responsibility. (DNLM)D012941
|
|
Drug Resistance. (DNLM)D004351
|
|
Communicable Diseases. (DNLM)D003141
|
|
Communicable diseases. (OCoLC)fst00869883
|
|
Bioethics. (OCoLC)fst00832038
|
|
Drug resistance. (OCoLC)fst00898701
|
| Added Author |
Jamrozik, Euzebiusz, editor.
|
|
Selgelid, Michael J., editor.
|
| Other Form: |
Print version: Ethics and drug resistance. Cham, Switzerland : Springer, [2020] 3030278735 9783030278731 (OCoLC)1107595917 |
| ISBN |
9783030278748 (electronic book) |
|
3030278743 (electronic book) |
|
3030278735 |
|
9783030278731 |
| Standard No. |
10.1007/978-3-030-27874-8 doi |
|
